BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 15, 2010
View Archived Issues
Clinical data indicate RTS,S/AS01E malaria vaccine is safe in infants and children
Read More
Phase I/IIa trial evaluates prime-boost vaccination with AdCh63-MSP1 and MVA-MSP1 malaria vaccines
Read More
Phase I/II trial shows safety of PfSPZ malaria vaccine in healthy volunteers
Read More
Neuraltus Pharma receives grants under QTDP
Read More
Pevion Biotech reports preliminary data from phase I PEV-7 trial
Read More
Flt3L level in CSF is putative biomarker for primary fibromyalgia and Sjogren's syndrome
Read More
Genome-wide meta-analysis suggests involvement of PGC-1-alpha in Parkinson's disease
Read More
Wyeth discovers new inhibitors of PI3K-alpha and mTOR
Read More
S-47445 to advance to phase I trials for neurogenerative diseases
Read More
Eisai claims novel cytidine deaminase inhibitors
Read More
Resolve Therapeutics licenses agents for autoimmune disease from University of Washington
Read More
Forest Labs and Janssen collaborate on Bystolic and Savella
Read More
GlobeImmune receives Federal Therapeutic Discovery Project Program grants
Read More
Emergent BioSolutions receives grants for oncology and autoimmunity programs
Read More
Pfizer claims new agonists of prostanoid EP2 and EP4 receptors
Read More
Infinity Pharma patents new inhibitors of fatty-acid amide hydrolase 1
Read More
Oligomerix obtains phase II NIH grant for Alzheimer's disease drug discovery
Read More
Ceregene raises funds to further develop CERE-120 and CERE-110
Read More
Merck Serono's Saizen recommended for approval in Europe
Read More
Cerulean Pharma closes series C financing led by Lilly Ventures
Read More
Epeius Biotech gets U.S. federal grant to further develop Rexin-G
Read More
Aires Pharma completes series B financing and enters option agreement with Novartis
Read More
Santarus launches Cycloset in U.S. to improve glycemic control in type 2 diabetes
Read More
Bausch & Lomb begins phase IIb trial of BOL-303259-X for reduction of intraocular pressure
Read More
Enrollment complete in phase IIb trial of V-5 immunitor
Read More